Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

9
(from Reference Citation Analysis)

Article PDFs (4)

Cited by > 0 (8)

Searched Name

Franco D. Rossi

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number

Citation Analysis

Zumbrun EE, Garvey CB, Wells JB, Lynn GC, Van Tongeren S, Steffens JT, Wetzel KS, Gomba LM, O’Brien KA, Rossi FD, Zeng X, Lee ED, Raymond JLW, Hoffman DA, Jay AN, Brown ES, Kallgren PA, Norris SL, Cantey-Kiser J, Kudiya H, Arthur C, Blair C, Babusis D, Chu VC, Singh B, Bannister R, Porter DP, Cihlar T, Dye JM. Characterization of the Cynomolgus Macaque Model of Marburg Virus Disease and Assessment of Timing for Therapeutic Treatment Testing. Viruses 2023;15:2335. [PMID: 38140576 PMCID: PMC10748006 DOI: 10.3390/v15122335] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2023] [Revised: 11/15/2023] [Accepted: 11/16/2023] [Indexed: 12/24/2023] Open

Affiliation(s)

Elizabeth E. Zumbrun United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA; (C.B.G.); (J.B.W.); (G.C.L.); (S.V.T.); (J.T.S.); (K.S.W.); (L.M.G.); (K.A.O.); (F.D.R.); (X.Z.); (E.D.L.); (J.L.W.R.); (D.A.H.); (A.N.J.); (E.S.B.); (P.A.K.); (S.L.N.); (J.M.D.)
Carly B. Garvey United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA; (C.B.G.); (J.B.W.); (G.C.L.); (S.V.T.); (J.T.S.); (K.S.W.); (L.M.G.); (K.A.O.); (F.D.R.); (X.Z.); (E.D.L.); (J.L.W.R.); (D.A.H.); (A.N.J.); (E.S.B.); (P.A.K.); (S.L.N.); (J.M.D.) Geneva Foundation, Tacoma, WA 98402, USA
Jay B. Wells United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA; (C.B.G.); (J.B.W.); (G.C.L.); (S.V.T.); (J.T.S.); (K.S.W.); (L.M.G.); (K.A.O.); (F.D.R.); (X.Z.); (E.D.L.); (J.L.W.R.); (D.A.H.); (A.N.J.); (E.S.B.); (P.A.K.); (S.L.N.); (J.M.D.) Geneva Foundation, Tacoma, WA 98402, USA
Ginger C. Lynn United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA; (C.B.G.); (J.B.W.); (G.C.L.); (S.V.T.); (J.T.S.); (K.S.W.); (L.M.G.); (K.A.O.); (F.D.R.); (X.Z.); (E.D.L.); (J.L.W.R.); (D.A.H.); (A.N.J.); (E.S.B.); (P.A.K.); (S.L.N.); (J.M.D.) Geneva Foundation, Tacoma, WA 98402, USA
Sean Van Tongeren United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA; (C.B.G.); (J.B.W.); (G.C.L.); (S.V.T.); (J.T.S.); (K.S.W.); (L.M.G.); (K.A.O.); (F.D.R.); (X.Z.); (E.D.L.); (J.L.W.R.); (D.A.H.); (A.N.J.); (E.S.B.); (P.A.K.); (S.L.N.); (J.M.D.) Geneva Foundation, Tacoma, WA 98402, USA
Jesse T. Steffens United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA; (C.B.G.); (J.B.W.); (G.C.L.); (S.V.T.); (J.T.S.); (K.S.W.); (L.M.G.); (K.A.O.); (F.D.R.); (X.Z.); (E.D.L.); (J.L.W.R.); (D.A.H.); (A.N.J.); (E.S.B.); (P.A.K.); (S.L.N.); (J.M.D.) Geneva Foundation, Tacoma, WA 98402, USA
Kelly S. Wetzel United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA; (C.B.G.); (J.B.W.); (G.C.L.); (S.V.T.); (J.T.S.); (K.S.W.); (L.M.G.); (K.A.O.); (F.D.R.); (X.Z.); (E.D.L.); (J.L.W.R.); (D.A.H.); (A.N.J.); (E.S.B.); (P.A.K.); (S.L.N.); (J.M.D.) Geneva Foundation, Tacoma, WA 98402, USA
Laura M. Gomba United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA; (C.B.G.); (J.B.W.); (G.C.L.); (S.V.T.); (J.T.S.); (K.S.W.); (L.M.G.); (K.A.O.); (F.D.R.); (X.Z.); (E.D.L.); (J.L.W.R.); (D.A.H.); (A.N.J.); (E.S.B.); (P.A.K.); (S.L.N.); (J.M.D.) Geneva Foundation, Tacoma, WA 98402, USA
Kristan A. O’Brien United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA; (C.B.G.); (J.B.W.); (G.C.L.); (S.V.T.); (J.T.S.); (K.S.W.); (L.M.G.); (K.A.O.); (F.D.R.); (X.Z.); (E.D.L.); (J.L.W.R.); (D.A.H.); (A.N.J.); (E.S.B.); (P.A.K.); (S.L.N.); (J.M.D.) Geneva Foundation, Tacoma, WA 98402, USA
Franco D. Rossi United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA; (C.B.G.); (J.B.W.); (G.C.L.); (S.V.T.); (J.T.S.); (K.S.W.); (L.M.G.); (K.A.O.); (F.D.R.); (X.Z.); (E.D.L.); (J.L.W.R.); (D.A.H.); (A.N.J.); (E.S.B.); (P.A.K.); (S.L.N.); (J.M.D.)
Xiankun Zeng United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA; (C.B.G.); (J.B.W.); (G.C.L.); (S.V.T.); (J.T.S.); (K.S.W.); (L.M.G.); (K.A.O.); (F.D.R.); (X.Z.); (E.D.L.); (J.L.W.R.); (D.A.H.); (A.N.J.); (E.S.B.); (P.A.K.); (S.L.N.); (J.M.D.)
Eric D. Lee United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA; (C.B.G.); (J.B.W.); (G.C.L.); (S.V.T.); (J.T.S.); (K.S.W.); (L.M.G.); (K.A.O.); (F.D.R.); (X.Z.); (E.D.L.); (J.L.W.R.); (D.A.H.); (A.N.J.); (E.S.B.); (P.A.K.); (S.L.N.); (J.M.D.)
Jo Lynne W. Raymond United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA; (C.B.G.); (J.B.W.); (G.C.L.); (S.V.T.); (J.T.S.); (K.S.W.); (L.M.G.); (K.A.O.); (F.D.R.); (X.Z.); (E.D.L.); (J.L.W.R.); (D.A.H.); (A.N.J.); (E.S.B.); (P.A.K.); (S.L.N.); (J.M.D.)
Diana A. Hoffman United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA; (C.B.G.); (J.B.W.); (G.C.L.); (S.V.T.); (J.T.S.); (K.S.W.); (L.M.G.); (K.A.O.); (F.D.R.); (X.Z.); (E.D.L.); (J.L.W.R.); (D.A.H.); (A.N.J.); (E.S.B.); (P.A.K.); (S.L.N.); (J.M.D.)
Alexandra N. Jay United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA; (C.B.G.); (J.B.W.); (G.C.L.); (S.V.T.); (J.T.S.); (K.S.W.); (L.M.G.); (K.A.O.); (F.D.R.); (X.Z.); (E.D.L.); (J.L.W.R.); (D.A.H.); (A.N.J.); (E.S.B.); (P.A.K.); (S.L.N.); (J.M.D.)
Elizabeth S. Brown United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA; (C.B.G.); (J.B.W.); (G.C.L.); (S.V.T.); (J.T.S.); (K.S.W.); (L.M.G.); (K.A.O.); (F.D.R.); (X.Z.); (E.D.L.); (J.L.W.R.); (D.A.H.); (A.N.J.); (E.S.B.); (P.A.K.); (S.L.N.); (J.M.D.) Geneva Foundation, Tacoma, WA 98402, USA
Paul A. Kallgren United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA; (C.B.G.); (J.B.W.); (G.C.L.); (S.V.T.); (J.T.S.); (K.S.W.); (L.M.G.); (K.A.O.); (F.D.R.); (X.Z.); (E.D.L.); (J.L.W.R.); (D.A.H.); (A.N.J.); (E.S.B.); (P.A.K.); (S.L.N.); (J.M.D.)
Sarah L. Norris United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA; (C.B.G.); (J.B.W.); (G.C.L.); (S.V.T.); (J.T.S.); (K.S.W.); (L.M.G.); (K.A.O.); (F.D.R.); (X.Z.); (E.D.L.); (J.L.W.R.); (D.A.H.); (A.N.J.); (E.S.B.); (P.A.K.); (S.L.N.); (J.M.D.)
Jean Cantey-Kiser PharPoint, Wilmington, NC 28405, USA
Humza Kudiya Gilead Sciences, Foster City, CA 94404, USA; (H.K.); (C.A.); (C.B.); (D.B.); (V.C.C.); (B.S.); (R.B.); (D.P.P.); (T.C.)
Chris Arthur Gilead Sciences, Foster City, CA 94404, USA; (H.K.); (C.A.); (C.B.); (D.B.); (V.C.C.); (B.S.); (R.B.); (D.P.P.); (T.C.)
Christiana Blair Gilead Sciences, Foster City, CA 94404, USA; (H.K.); (C.A.); (C.B.); (D.B.); (V.C.C.); (B.S.); (R.B.); (D.P.P.); (T.C.)
Darius Babusis Gilead Sciences, Foster City, CA 94404, USA; (H.K.); (C.A.); (C.B.); (D.B.); (V.C.C.); (B.S.); (R.B.); (D.P.P.); (T.C.)
Victor C. Chu Gilead Sciences, Foster City, CA 94404, USA; (H.K.); (C.A.); (C.B.); (D.B.); (V.C.C.); (B.S.); (R.B.); (D.P.P.); (T.C.)
Bali Singh Gilead Sciences, Foster City, CA 94404, USA; (H.K.); (C.A.); (C.B.); (D.B.); (V.C.C.); (B.S.); (R.B.); (D.P.P.); (T.C.)
Roy Bannister Gilead Sciences, Foster City, CA 94404, USA; (H.K.); (C.A.); (C.B.); (D.B.); (V.C.C.); (B.S.); (R.B.); (D.P.P.); (T.C.)
Danielle P. Porter Gilead Sciences, Foster City, CA 94404, USA; (H.K.); (C.A.); (C.B.); (D.B.); (V.C.C.); (B.S.); (R.B.); (D.P.P.); (T.C.)
Tomas Cihlar Gilead Sciences, Foster City, CA 94404, USA; (H.K.); (C.A.); (C.B.); (D.B.); (V.C.C.); (B.S.); (R.B.); (D.P.P.); (T.C.)
John M. Dye United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA; (C.B.G.); (J.B.W.); (G.C.L.); (S.V.T.); (J.T.S.); (K.S.W.); (L.M.G.); (K.A.O.); (F.D.R.); (X.Z.); (E.D.L.); (J.L.W.R.); (D.A.H.); (A.N.J.); (E.S.B.); (P.A.K.); (S.L.N.); (J.M.D.)

Collapse

Bixler SL, Stefan CP, Jay AN, Rossi FD, Ricks KM, Shoemaker CJ, Moreau AM, Zeng X, Hooper JW, Dyer DN, Frick OM, Koehler JW, Kearney BJ, DiPinto N, Liu J, Tostenson SD, Clements TL, Smith JM, Johnson JA, Berrier KL, Esham HL, Delp KL, Coyne SR, Bloomfield HA, Kuehnert PA, Akers K, Gibson KM, Minogue TD, Nalca A, Pitt MLM. Exposure Route Influences Disease Severity in the COVID-19 Cynomolgus Macaque Model. Viruses 2022;14:v14051013. [PMID: 35632755 PMCID: PMC9145782 DOI: 10.3390/v14051013] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2022] [Revised: 04/29/2022] [Accepted: 05/05/2022] [Indexed: 02/04/2023] Open

Affiliation(s)

Sandra L. Bixler Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA; (J.W.H.); (J.M.S.) Correspondence: (S.L.B.); (M.L.M.P.); Tel.: +1-301-619-3014 (S.L.B.); +1-301-619-4230 (M.L.M.P.)
Christopher P. Stefan Diagnostic Systems Division, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (C.P.S.); (K.M.R.); (C.J.S.); (J.W.K.); (T.L.C.); (K.L.D.); (S.R.C.); (P.A.K.); (T.D.M.)
Alexandra N. Jay Veterinary Medicine Division, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (A.N.J.); (F.D.R.); (D.N.D.); (O.M.F.); (K.L.B.); (H.L.E.)
Franco D. Rossi Veterinary Medicine Division, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (A.N.J.); (F.D.R.); (D.N.D.); (O.M.F.); (K.L.B.); (H.L.E.)
Keersten M. Ricks Diagnostic Systems Division, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (C.P.S.); (K.M.R.); (C.J.S.); (J.W.K.); (T.L.C.); (K.L.D.); (S.R.C.); (P.A.K.); (T.D.M.)
Charles J. Shoemaker Diagnostic Systems Division, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (C.P.S.); (K.M.R.); (C.J.S.); (J.W.K.); (T.L.C.); (K.L.D.); (S.R.C.); (P.A.K.); (T.D.M.)
Alicia M. Moreau Pathology Division, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (A.M.M.); (X.Z.); (N.D.); (J.L.)
Xiankun Zeng Pathology Division, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (A.M.M.); (X.Z.); (N.D.); (J.L.)
Jay W. Hooper Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA; (J.W.H.); (J.M.S.)
David N. Dyer Veterinary Medicine Division, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (A.N.J.); (F.D.R.); (D.N.D.); (O.M.F.); (K.L.B.); (H.L.E.)
Ondraya M. Frick Veterinary Medicine Division, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (A.N.J.); (F.D.R.); (D.N.D.); (O.M.F.); (K.L.B.); (H.L.E.)
Jeffrey W. Koehler Diagnostic Systems Division, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (C.P.S.); (K.M.R.); (C.J.S.); (J.W.K.); (T.L.C.); (K.L.D.); (S.R.C.); (P.A.K.); (T.D.M.)
Brian J. Kearney Core Laboratory Services, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (B.J.K.); (S.D.T.); (J.A.J.); (H.A.B.); (K.A.); (K.M.G.)
Nina DiPinto Pathology Division, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (A.M.M.); (X.Z.); (N.D.); (J.L.)
Jun Liu Pathology Division, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (A.M.M.); (X.Z.); (N.D.); (J.L.)
Samantha D. Tostenson Core Laboratory Services, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (B.J.K.); (S.D.T.); (J.A.J.); (H.A.B.); (K.A.); (K.M.G.)
Tamara L. Clements Diagnostic Systems Division, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (C.P.S.); (K.M.R.); (C.J.S.); (J.W.K.); (T.L.C.); (K.L.D.); (S.R.C.); (P.A.K.); (T.D.M.)
Jeffrey M. Smith Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA; (J.W.H.); (J.M.S.)
Joshua A. Johnson Core Laboratory Services, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (B.J.K.); (S.D.T.); (J.A.J.); (H.A.B.); (K.A.); (K.M.G.)
Kerry L. Berrier Veterinary Medicine Division, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (A.N.J.); (F.D.R.); (D.N.D.); (O.M.F.); (K.L.B.); (H.L.E.)
Heather L. Esham Veterinary Medicine Division, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (A.N.J.); (F.D.R.); (D.N.D.); (O.M.F.); (K.L.B.); (H.L.E.)
Korey L. Delp Diagnostic Systems Division, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (C.P.S.); (K.M.R.); (C.J.S.); (J.W.K.); (T.L.C.); (K.L.D.); (S.R.C.); (P.A.K.); (T.D.M.)
Susan R. Coyne Diagnostic Systems Division, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (C.P.S.); (K.M.R.); (C.J.S.); (J.W.K.); (T.L.C.); (K.L.D.); (S.R.C.); (P.A.K.); (T.D.M.)
Holly A. Bloomfield Core Laboratory Services, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (B.J.K.); (S.D.T.); (J.A.J.); (H.A.B.); (K.A.); (K.M.G.)
Paul A. Kuehnert Diagnostic Systems Division, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (C.P.S.); (K.M.R.); (C.J.S.); (J.W.K.); (T.L.C.); (K.L.D.); (S.R.C.); (P.A.K.); (T.D.M.)
Kristen Akers Core Laboratory Services, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (B.J.K.); (S.D.T.); (J.A.J.); (H.A.B.); (K.A.); (K.M.G.)
Kathleen M. Gibson Core Laboratory Services, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (B.J.K.); (S.D.T.); (J.A.J.); (H.A.B.); (K.A.); (K.M.G.)
Timothy D. Minogue Diagnostic Systems Division, USAMRIID, Fort Detrick, Frederick, MD 21702, USA; (C.P.S.); (K.M.R.); (C.J.S.); (J.W.K.); (T.L.C.); (K.L.D.); (S.R.C.); (P.A.K.); (T.D.M.)
Aysegul Nalca Core Support Directorate, USAMRIID, Fort Detrick, Frederick, MD 21702, USA;
Margaret L. M. Pitt Office of the Science Advisor, USAMRIID, Fort Detrick, Frederick, MD 21702, USA Correspondence: (S.L.B.); (M.L.M.P.); Tel.: +1-301-619-3014 (S.L.B.); +1-301-619-4230 (M.L.M.P.)

Collapse

Liu J, Trefry JC, Babka AM, Schellhase CW, Coffin KM, Williams JA, Raymond JLW, Facemire PR, Chance TB, Davis NM, Scruggs JL, Rossi FD, Haddow AD, Zelko JM, Bixler SL, Crozier I, Iversen PL, Pitt ML, Kuhn JH, Palacios G, Zeng X. Ebola virus persistence and disease recrudescence in the brains of antibody-treated nonhuman primate survivors. Sci Transl Med 2022;14:eabi5229. [PMID: 35138912 DOI: 10.1126/scitranslmed.abi5229] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]

Affiliation(s)

Jun Liu United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA
John C Trefry United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA
April M Babka United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA
Christopher W Schellhase United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA
Kayla M Coffin United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA
Janice A Williams United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA
Jo Lynne W Raymond United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA
Paul R Facemire United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA
Taylor B Chance United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA
Neil M Davis United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA
Jennifer L Scruggs United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA
Franco D Rossi United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA
Andrew D Haddow United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA
Justine M Zelko United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA
Sandra L Bixler United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA
Ian Crozier Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA
Patrick L Iversen United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA
Margaret L Pitt United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA
Jens H Kuhn Integrated Research Facility at Fort Detrick (IRF-Frederick), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Frederick, MD 21702, USA
Gustavo Palacios United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA
Xiankun Zeng United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA

Collapse

Waag DM, Chance TB, Trevino SR, Rossi FD, Fetterer DP, Amemiya K, Dankmeyer JL, Ingavale SS, Tobery SA, Zeng X, Kern SJ, Worsham PL, Cote CK, Welkos SL. Comparison of three non-human primate aerosol models for glanders, caused by Burkholderia mallei. Microb Pathog 2021;155:104919. [PMID: 33915206 DOI: 10.1016/j.micpath.2021.104919] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2021] [Revised: 03/30/2021] [Accepted: 04/01/2021] [Indexed: 01/15/2023]

Abstract

Burkholderia mallei is a gram-negative obligate animal pathogen that causes glanders, a highly contagious and potentially fatal disease of solipeds including horses, mules, and donkeys. Humans are also susceptible, and exposure can result in a wide range of clinical forms, i.e., subclinical infection, chronic forms with remission and exacerbation, or acute and potentially lethal septicemia and/or pneumonia. Due to intrinsic antibiotic resistance and the ability of the organisms to survive intracellularly, current treatment regimens are protracted and complicated; and no vaccine is available. As a consequence of these issues, and since B. mallei is infectious by the aerosol route, B. mallei is regarded as a major potential biothreat agent. To develop optimal medical countermeasures and diagnostic tests, well characterized animal models of human glanders are needed. The goal of this study was to perform a head-to-head comparison of models employing three commonly used nonhuman primate (NHP) species, the African green monkey (AGM), Rhesus macaque, and the Cynomolgus macaque. The natural history of infection and in vitro clinical, histopathological, immunochemical, and bacteriological parameters were examined. The AGMs were the most susceptible NHP to B. mallei; five of six expired within 14 days. Although none of the Rhesus or Cynomolgus macaques succumbed, the Rhesus monkeys exhibited abnormal signs and clinical findings associated with B. mallei infection; and the latter may be useful for modeling chronic B. mallei infection. Based on the disease progression observations, gross and histochemical pathology, and humoral and cellular immune response findings, the AGM appears to be the optimal model of acute, lethal glanders infection. AGM models of infection by B. pseudomallei, the etiologic agent of melioidosis, have been characterized recently. Thus, the selection of the AGM species provides the research community with a single NHP model for investigations on acute, severe, inhalational melioidosis and glanders.

Collapse

Affiliation(s)

David M Waag Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA
Taylor B Chance Pathology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA
Sylvia R Trevino Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA
Franco D Rossi Applied and Advanced Technology-Aerobiology, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA
David P Fetterer Biostatistics Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA
Kei Amemiya Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA
Jennifer L Dankmeyer Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA
Susham S Ingavale Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA
Steven A Tobery Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA
Xiankun Zeng Pathology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA
Steven J Kern Biostatistics Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA
Patricia L Worsham Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA
Christopher K Cote Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA.
Susan L Welkos Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA.

Collapse

Haddow AD, Perez-Sautu U, Wiley MR, Miller LJ, Kimmel AE, Principe LM, Wollen-Roberts SE, Shamblin JD, Valdez SM, Cazares LH, Pratt WD, Rossi FD, Lugo-Roman L, Bavari S, Palacios GF, Nalca A, Nasar F, Pitt MLM. Modeling mosquito-borne and sexual transmission of Zika virus in an enzootic host, the African green monkey. PLoS Negl Trop Dis 2020;14:e0008107. [PMID: 32569276 PMCID: PMC7343349 DOI: 10.1371/journal.pntd.0008107] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2019] [Revised: 07/08/2020] [Accepted: 02/01/2020] [Indexed: 01/08/2023] Open

Abstract

Mosquito-borne and sexual transmission of Zika virus (ZIKV), a TORCH pathogen, recently initiated a series of large epidemics throughout the Tropics. Animal models are necessary to determine transmission risk and study pathogenesis, as well screen antivirals and vaccine candidates. In this study, we modeled mosquito and sexual transmission of ZIKV in the African green monkey (AGM). Following subcutaneous, intravaginal or intrarectal inoculation of AGMs with ZIKV, we determined the transmission potential and infection dynamics of the virus. AGMs inoculated by all three transmission routes exhibited viremia and viral shedding followed by strong virus neutralizing antibody responses, in the absence of clinical illness. All four of the subcutaneously inoculated AGMs became infected (mean peak viremia: 2.9 log₁₀ PFU/mL, mean duration: 4.3 days) and vRNA was detected in their oral swabs, with infectious virus being detected in a subset of these specimens. Although all four of the intravaginally inoculated AGMs developed virus neutralizing antibody responses, only three had detectable viremia (mean peak viremia: 4.0 log₁₀ PFU/mL, mean duration: 3.0 days). These three AGMs also had vRNA and infectious virus detected in both oral and vaginal swabs. Two of the four intrarectally inoculated AGMs became infected (mean peak viremia: 3.8 log₁₀ PFU/mL, mean duration: 3.5 days). vRNA was detected in oral swabs collected from both of these infected AGMs, and infectious virus was detected in an oral swab from one of these AGMs. Notably, vRNA and infectious virus were detected in vaginal swabs collected from the infected female AGM (peak viral load: 7.5 log₁₀ copies/mL, peak titer: 3.8 log₁₀ PFU/mL, range of detection: 5–21 days post infection). Abnormal clinical chemistry and hematology results were detected and acute lymphadenopathy was observed in some AGMs. Infection dynamics in all three AGM ZIKV models are similar to those reported in the majority of human ZIKV infections. Our results indicate that the AGM can be used as a surrogate to model mosquito or sexual ZIKV transmission and infection. Furthermore, our results suggest that AGMs are likely involved in the enzootic maintenance and amplification cycle of ZIKV.

Zika virus (ZIKV) is primarily maintained in an enzootic cycle involving nonhuman primates and mosquitoes, with epizootics and epidemics occurring when the virus is introduced into naïve populations of nonhuman primates or humans, respectively. While, the primary transmission mechanism of the virus is by the bite on an infected mosquito, ZIKV can also be sexually transmitted. In an effort to develop novel animal models to study ZIKV disease, and to better understand the role of nonhuman primates as amplification and maintenance hosts of ZIKV in nature, we modeled mosquito-borne and sexual transmission of ZIKV in the enzootic host, the African green monkey (AGM). Infection dynamics and neutralizing antibody responses in all three AGM ZIKV models (subcutaneous, intravaginal and intrarectal) in the absence of clinical illness–recapitulated reported generalized human disease course. Furthermore, we detected prolonged shedding with high viral loads and infectious virus in the vaginal swabs collected from an infected female AGM inoculated intrarectally. Notably, these results support limited human clinical evidence that ZIKV transmission can occur during female-to-male vaginal sexual acts, and furthermore indicate the existence of ZIKV super-spreaders. Finally, our results indicate sexual transmission of ZIKV could occur among infected nonhuman primates (e.g. Chlorocebus spp.) in Africa and may serve as a secondary transmission and maintenance mechanism in the absence of mosquito-to-nonhuman primate transmission.

Collapse

Affiliation(s)

Andrew D. Haddow Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America * E-mail:
Unai Perez-Sautu Center for Genome Sciences, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America
Michael R. Wiley Center for Genome Sciences, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America
Lynn J. Miller Veterinary Medicine Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America
Adrienne E. Kimmel Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America
Lucia M. Principe Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America
Suzanne E. Wollen-Roberts Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America
Joshua D. Shamblin Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America
Stephanie M. Valdez Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America
Lisa H. Cazares Molecular and Translational Sciences Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America
William D. Pratt Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America
Franco D. Rossi Aerobiology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America
Luis Lugo-Roman Veterinary Medicine Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America
Sina Bavari Molecular and Translational Sciences Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America
Gustavo F. Palacios Center for Genome Sciences, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America
Aysegul Nalca Aerobiology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America
Farooq Nasar Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America
M. Louise M. Pitt Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America

Collapse

Pascal KE, Dudgeon D, Trefry JC, Anantpadma M, Sakurai Y, Murin CD, Turner HL, Fairhurst J, Torres M, Rafique A, Yan Y, Badithe A, Yu K, Potocky T, Bixler SL, Chance TB, Pratt WD, Rossi FD, Shamblin JD, Wollen SE, Zelko JM, Carrion R, Worwa G, Staples HM, Burakov D, Babb R, Chen G, Martin J, Huang TT, Erlandson K, Willis MS, Armstrong K, Dreier TM, Ward AB, Davey RA, Pitt MLM, Lipsich L, Mason P, Olson W, Stahl N, Kyratsous CA. Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates. J Infect Dis 2019;218:S612-S626. [PMID: 29860496 PMCID: PMC6249601 DOI: 10.1093/infdis/jiy285] [Citation(s) in RCA: 118] [Impact Index Per Article: 23.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open

Affiliation(s)

Kristen E Pascal Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Drew Dudgeon Regeneron Pharmaceuticals, Inc., Tarrytown, New York
John C Trefry Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland
Manu Anantpadma Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio
Yasuteru Sakurai Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio
Charles D Murin Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California
Hannah L Turner Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California
Jeanette Fairhurst Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Marcela Torres Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Ashique Rafique Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Ying Yan Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Ashok Badithe Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Kevin Yu Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Terra Potocky Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Sandra L Bixler Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland
Taylor B Chance Pathology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland
William D Pratt Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland
Franco D Rossi Center for Aerobiological Sciences, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland
Joshua D Shamblin Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland
Suzanne E Wollen Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland
Justine M Zelko Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland
Ricardo Carrion Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio
Gabriella Worwa Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio
Hilary M Staples Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio
Darya Burakov Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Robert Babb Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Gang Chen Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Joel Martin Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Tammy T Huang Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Karl Erlandson Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC
Melissa S Willis Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC
Kimberly Armstrong Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC
Thomas M Dreier Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC
Andrew B Ward Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California
Robert A Davey Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio
Margaret L M Pitt Office of the Commander, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland
Leah Lipsich Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Peter Mason Regeneron Pharmaceuticals, Inc., Tarrytown, New York
William Olson Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Neil Stahl Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Christos A Kyratsous Regeneron Pharmaceuticals, Inc., Tarrytown, New York

Collapse

Haddow AD, Nalca A, Rossi FD, Miller LJ, Wiley MR, Perez-Sautu U, Washington SC, Norris SL, Wollen-Roberts SE, Shamblin JD, Kimmel AE, Bloomfield HA, Valdez SM, Sprague TR, Principe LM, Bellanca SA, Cinkovich SS, Lugo-Roman L, Cazares LH, Pratt WD, Palacios GF, Bavari S, Pitt ML, Nasar F. High Infection Rates for Adult Macaques after Intravaginal or Intrarectal Inoculation with Zika Virus. Emerg Infect Dis 2017;23:1274-1281. [PMID: 28548637 PMCID: PMC5547779 DOI: 10.3201/eid2308.170036] [Citation(s) in RCA: 61] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open

Dias R, Xavier MG, Rossi FD, Neves MV, Lange TAP, Giongo A, De Rose CAF, Triplett EW. MPI-blastn and NCBI-TaxCollector: improving metagenomic analysis with high performance classification and wide taxonomic attachment. J Bioinform Comput Biol 2015;12:1450013. [PMID: 24969751 DOI: 10.1142/s0219720014500139] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]

Rossi FD, Saturno WA, Hurst H. Maya Codex Book Production and the Politics of Expertise: Archaeology of a Classic Period Household at Xultun, Guatemala. AMERICAN ANTHROPOLOGIST 2015. [DOI: 10.1111/aman.12167] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]